Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001013594-24-001040
Filing Date
2024-12-23
Accepted
2024-12-23 20:48:14
Documents
1
Period of Report
2024-12-12

Document Format Files

Seq Description Document Type Size
1 form3.html 3  
1 form3.xml 3 3025
  Complete submission text file 0001013594-24-001040.txt   4759
Mailing Address 2430 N. HALSTED ST. CHICAGO IL 60614
Business Address 2430 N. HALSTED ST. CHICAGO IL 60614 847-673-1700
EXICURE, INC. (Issuer) CIK: 0001698530 (see all company filings)

EIN.: 815333008 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 49F, PARC.1, 108, YEOUI-DAERO YEONGDEUNGPO-GU SEOUL M5 07335
Business Address 49F, PARC.1, 108, YEOUI-DAERO YEONGDEUNGPO-GU SEOUL M5 07335 82-2-1566-0900
SANGSANGIN INVESTMENT & SECURITIES CO., LTD. (Reporting) CIK: 0002049712 (see all company filings)

State of Incorp.: M5 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-39011 | Film No.: 241575427